In the fight against the new coronavirus, doctors are using medicinal products that were initially developed to treat other pathologies. The FAMHP summarises the actions and measures that have been taken.
News FAMHP
There are 13 result(s) found based on your search criteria
11-13 from 13 result(s)
Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation
Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.
Jean-Michel Dogné, pharmacovigilance expert at the FAMHP, is appointed member of the World Health Organization's Global Advisory Committee on Vaccine Safety
Jean-Michel Dogné has been putting his expertise at the service of the FAMHP for many years. The Belgian expertise in vaccines is recognised worldwide with his recent appointment as a member of the Global Advisory Committee on Vaccine Safety (GACVS) of the World Health Organisation (WHO).